Additionally, when compared with all controls, DKK1 maintained diagnostic accuracy in patients with HCC who did not have elevated levels of α-FP (AUROC 84, sensitivity 70.4%, and specificity 90% in the test cohort), AUROC 87%, sensitivity 66.7%, and specificity 87.2%. This evidence concerns the gene DKK1 and hepatocellular carcinoma.